New personalized immunotherapy shrinks colon cancer tumors

medicine Monday, July 15, 2024 Bethesda/Maryland – A new variant of adoptive cell transfer, which transfers receptors from T cells from the patient’s cancer metastases to defense cells in the laboratory and then administers these